The Global HIV Diagnostics Market Was Valued At Us$ 3,050.8 Million In 2018, And Is Expected To Exhibit A Cagr Of 9.2% Over The Forecast Period (2019-2027).
HIV, also known as human immunodeficiency virus, is a virus that interferes with the functioning of cells in the body that protect against harmful diseases and infections. HIV infection is contagious and can be spread through contact with infected blood, sperm, or vaginal fluids. HIV Diagnostics is thus a medical technology used to determine whether a person is HIV positive or negative. One of the major factors driving growth in the demand for HIV Diagnostics systems is the rise in the prevalence of HIV infection. Rising R&D expenditure by major healthcare companies, combined with increased application of HIV antigen, nucleic acid testing, and viral load testing, will generate lucrative and remunerative growth opportunities for the market.
Because of rising government initiatives to control hiv infection, the HIV Diagnostics Market is expected to grow significantly. For example, the Ministry of Health and Family Welfare of the Government of India launched the 'Test and Treat Policy for HIV' policy in April 2017, which is expected to improve the longevity and quality of life of those infected with HIV. Furthermore, the Ministry of Health in Sri Lanka launched the National HIV/STI Strategic Plan (NSP) Sri Lanka 2018-2022 in 2017. This strategic plan includes five objectives that will support NSP's vision of eliminating new HIV infections, discrimination, and AIDS-related deaths in the country. The HIV diagnostics market is expected to grow significantly as market players adopt more agreement and collaboration strategies.
Comments
Post a Comment